An Open Labelled, Randomized, Multicentre, Comparative study to evaluate the immunogenicity and reactogenicity of Inactivated Polio Vaccine (Panacea Biotec Ltd.) with Imovax Polio (Inactivated Poliomyelitis Vaccine, Sanofi Pasteur India Pvt Ltd) in infants.

Trial Profile

An Open Labelled, Randomized, Multicentre, Comparative study to evaluate the immunogenicity and reactogenicity of Inactivated Polio Vaccine (Panacea Biotec Ltd.) with Imovax Polio (Inactivated Poliomyelitis Vaccine, Sanofi Pasteur India Pvt Ltd) in infants.

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Sep 2016

At a glance

  • Drugs Poliovirus vaccine inactivated (Primary)
  • Indications Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Poliomyelitis; Tetanus
  • Focus Pharmacodynamics
  • Sponsors Panacea Biotec
  • Most Recent Events

    • 16 Jan 2013 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India.
    • 21 Aug 2010 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India record.
    • 12 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top